Wednesday, December 23, 2015

AZ Innovative Medicines and Early Development Graduate Programme

Also, from the inbox, an invitation to apply for the AstraZeneca Innovative Medicines and Early Development Graduate Programme:
...the IMED Graduate programme is a global initiative designed to provide high-calibre science graduates with a two-year placement in the company, with the potential for long-term career development. The programme was launched in 2013 and we have now successfully recruited and on boarded 75 graduates on the programme across IMED and who are directly contributing to our science and projects across our core R&D Sites in the UK/US and Sweden.   
The programme is very much focused on breath of experience and our graduates are encouraged to undertake broad scientific placements that will provide them with the solid foundations to be great scientists for the future.  Each graduate will be required to complete 3 eight months rotations as part of the programme. Graduates are also provided with a mentor for the duration of the programme whose aim is to provide the career support and guidance to ensure that they are being developed to their full potential.
The US deadline is January 29, and the UK deadline is March 4. Best wishes to those interested.  


  1. Sounds kinda like a graduate program in coal mining, steel milling, or typewriter repair.

  2. At least it's a tradeschool-like opportunity for many who would otherwise not be able to find work in the field after getting their bachelors. It gives you important experience and a really good chance in the industry after you finish it; something that already exists for a long time in the German industry. Everybody is always complaining how a bachelors in chemistry doesn't give you practical experience of actually working in a lab for a long time, and how the economics of the industry work.

    If you're going to be that negative about it, you should petition for universities to stop teaching chemistry, or at least to stop giving degrees in chemistry. Heyzeus, you just can't win with some people.

    1. I think an industrially-focused training program is a good idea, but of all the industries employing chemists, I'm really surprised that a pharma company is seeing any shortage of experienced applicants.

      I suspect a lot of the Pfizer carnage is now far enough in the past that technician and BS-level people who lost their jobs are now at regular chemical companies like Dow or BASF (or out of science entirely), so finding a seasoned pharma technician might be harder than it looks.

  3. These rotation programs exist widely in engineering disciplines too...